Metastasis-Associated Protein 1 Deficiency Results in Compromised Pulmonary Alveolar Capillary Angiogenesis in Mice. by Qin, Jun-Hui et al.
Himmelfarb Health Sciences Library, The George Washington University
Health Sciences Research Commons
Biochemistry and Molecular Medicine Faculty
Publications Biochemistry and Molecular Medicine
8-15-2017
Metastasis-Associated Protein 1 Deficiency Results
in Compromised Pulmonary Alveolar Capillary
Angiogenesis in Mice.
Jun-Hui Qin
Zhen-Yu Ke
Qiang Zhou
Li Wang
Yuan Liang
See next page for additional authors
Follow this and additional works at: https://hsrc.himmelfarb.gwu.edu/smhs_biochem_facpubs
Part of the Molecular Biology Commons
This Journal Article is brought to you for free and open access by the Biochemistry and Molecular Medicine at Health Sciences Research Commons. It
has been accepted for inclusion in Biochemistry and Molecular Medicine Faculty Publications by an authorized administrator of Health Sciences
Research Commons. For more information, please contact hsrc@gwu.edu.
APA Citation
Qin, J., Ke, Z., Zhou, Q., Wang, L., Liang, Y., Wang, Y., Yang, T., Gao, X., Ye, J., Kumar, R., & Wang, R. (2017). Metastasis-Associated
Protein 1 Deficiency Results in Compromised Pulmonary Alveolar Capillary Angiogenesis in Mice.. Medical Science Monitor :
International Medical Journal of Experimental and Clinical Research, 23 (). http://dx.doi.org/10.12659/MSM.905992
Authors
Jun-Hui Qin, Zhen-Yu Ke, Qiang Zhou, Li Wang, Yuan Liang, Ying-Mei Wang, Tong Yang, Xing Gao, Jing Ye,
Rekesh Kumar, and Rui-An Wang
This journal article is available at Health Sciences Research Commons: https://hsrc.himmelfarb.gwu.edu/smhs_biochem_facpubs/
254
Received: 2017.06.30
Accepted: 2017.07.24
Published: 2017.08.15
 2614   1   7   29
Metastasis-Associated Protein 1 Deficiency 
Results in Compromised Pulmonary Alveolar 
Capillary Angiogenesis in Mice
 BCDE 1 Jun-Hui Qin
 C 1 Zhen-Yu Ke
 C 2 Qiang Zhou
 B 1 Li Wang
 B 1 Yuan Liang
 F 1 Ying-Mei Wang
 B 1 Tong Yang
 F 1 Xing Gao
 A 1 Jing Ye*
 C 3,4 Rakesh Kumar
 G 1,5 Rui-An Wang*
  * Rui-An Wang and Jing Ye contributed equally to this work
 Corresponding Authors: Rui-An Wang, e-mail: wangra@fmmu.edu.cn; Jing Ye, e-mail: yejing@fmmu.edu.cn
 Source of support: This study was supported by the National Natural Science Foundation of China (NSFC): 30870923; 30971535
 Background: The aim of this study was to investigate the effects of metastasis-associated protein 1 (MTA1) deficiency during 
angiogenesis of pulmonary alveolar capillaries in mice and to determine the molecular mechanisms involved.
 Material/Methods: The expressions of MTA1, CD34, vascular endothelial growth factor (VEGF), alpha smooth muscle actin (a-SMA), 
and HIF-1a were analyzed in the lungs of MTA1-knockout (KO) and wild-type mice at embryonic day 18.5 and 
2 months by quantitative PCR, immunoblotting, and immunohistochemistry. The morphological changes were 
investigated during pulmonary alveolar capillary formation. The heart weight/body weight (HW/BW) ratio and 
the size of the right ventricular wall cardiomyocytes were also measured. Regulation of MTA1 on HIF-1a was 
determined in vitro.
 Results: MTA1 deficiency reduced the number of pulmonary alveolar capillaries compared to the wild-type mice. MTA1-
KO mice exhibited a decreased expression of HIF-1a and VEGF in the lungs. The retarded growth of the MTA1-
KO mice was also noticed during the first week after birth. Accordingly, MTA1 deficiency resulted in increased 
infant mortality. In surviving adult mice, MTA1 deficiency induced myocardial hypertrophy, highlighted by an 
increased heart weight/body weight ratio and larger cardiomyocytes. In cultured cells, HIF-1a and VEGF lev-
els were significantly upregulated upon MTA1 overexpression, suggesting a close relationship between all 3 
molecules.
 Conclusions: MTA1 participates in the formation of pulmonary capillaries via stabilization of HIF-1a. This finding sheds new 
light on the function of MTA1 in lung development, opening new avenues for the diagnosis/treatment of relat-
ed pulmonary diseases.
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Background
Metastasis-associated protein 1 (MTA1), a member of the nu-
cleosome remodeling and decarboxylation complex (NuRD) 
family, has a profound role in pathological and physiologi-
cal processes, and is highly expressed in mouse tissues and 
organs [1–3]. MTA1 regulates the expression of target genes 
due to its corepressor or coactivator activity [4]. In addition, 
MTA1 influences biological functions by modifying the stabili-
ty of target proteins via deacetylation of non-histone proteins 
such as hypoxia-inducible factor 1-alpha (HIF-1a) by MTA1/his-
tone deacetylases (HDACs) [5]. MTA1 expression correlates well 
with tumor angiogenesis, as well as with HIF-1a and its target 
genes such as vascular endothelial growth factor (VEGF) [5–7]. 
Previous research has shown that specific HDACs induce an-
giogenesis and influence the stability of HIF-1a in mice [8,9].
Vascular development in the lungs is a complex, multistep 
process controlled by several factors, including HIF-1a and 
VEGF [10–12]. Notably, pulmonary vascular endothelial cells 
play a crucial role in regulating the pulmonary vascular sys-
tem, and in maintaining barrier function and integrity of al-
veolar capillary membranes [13]. These cells, as well as other 
cell types in the lungs, express high levels of VEGF, which has 
been shown to be essential during fetal lung development, 
a process critically dependent on oxygen tension and angio-
genesis [14]. Accordingly, administration of VEGF initiates the 
process of vessel formation [15,16]. Transcription of VEGF is 
regulated by HIF-1a, a target of MTA1 [17,18]. In addition, in-
creased HIF-1a expression and its nuclear translocation are 
associated with pronounced angiogenesis [13,19]. These ob-
servations suggest that expression of HIF-1a and VEGF is in-
tegral to the process of angiogenesis. Although HDACs induce 
angiogenesis and influence the levels of HIF-1a in mice [8,9], 
the role of MTA1 and HIF-1a in promoting angiogenesis dur-
ing lung development remains unknown.
The present study was designed to determine the contribu-
tion of MTA1 and its downstream pathways during pulmo-
nary vascular development in MTA1-knockout (KO) mice. Our 
results suggest that MTA1 facilitates the angiogenesis of pul-
monary alveolar capillaries by stabilizing HIF-1a, opening the 
possibility of new diagnosis and treatments for related pul-
monary diseases.
Material and Methods
Animals and tissue collection
MTA1-KO mice were kindly provided by Dr. Rakesh Kumar’s 
laboratory and were handled according to the Care and Use 
of Laboratory Animals guidelines of Fourth Military Medical 
University. The animals were maintained under a 12-h light/12-h 
dark cycle with ad libitum access to water and chow diet. Before 
sacrificing and tissue collection, animals were fasted for 4 h. 
Tissues were collected and either directly fixed in 4% form-
aldehyde to produce paraffin sections or flash-frozen in liq-
uid nitrogen followed by storage at –80°C for further protein 
and mRNA analysis. The age of the fetus was determined rel-
ative to the date on which the vaginal plug was found, which 
was set to 0.5 E.
Cell culture and transfection of an MTA1 overexpression 
vector
293T cells were grown in medium supplemented with 10% fe-
tal bovine serum and 1× antibiotic-antimycotic solution in a 
humidified incubator with 5% CO2 at 37°C. Cell culture medium 
and additives were obtained from Gibco (Invitrogen). MLE-12 
cells were obtained from the Cell Center of Fudan University 
(China). Cells were cultured in HITES (hydrocortisone, insulin, 
transferrin, estrogen) medium (Gibco) supplemented with 10% 
fetal bovine serum (FBS) and 2 mM glutamine at 37°C under 
conditions of 5% CO2. Transient transfections were performed 
using Lipofectamine 2000 (Invitrogen) according to the man-
ufacturer’s instructions.
Antibodies and reagents
Sources of antibodies were as follows: MTA1 (D40D1) XP® rab-
bit mAb (#5647, Cell Signaling Technology); CD31 (PECAM-1) 
(D8V9E) XP® rabbit mAb (#77699, Cell Signaling Technology); 
rabbit anti-CD34 (BA0532, Boster Bio-Technology Co., LTD); 
rabbit anti-VEGF (BA0407, Boster Bio-Technology Co., LTD); 
ERG (A7L1G) Rabbit mAb (#97249, Cell Signaling Technology); 
rabbit anti-HIF-1a/HIF1A (PB0245, Boster Bio-Technology Co., 
LTD); rabbit anti-alpha smooth muscle actin (a-SMA) (ab5694, 
Abcam); and b-actin (Abcam). MTA1-pIRES2-EGFP was from 
Dongao-Technology Co., LTD. Biotinylated rabbit anti-goat IgG 
secondary antibody (K0675, Dako), streptavidin-horseradish 
peroxidase (HRP) (K0675, Dako), and 3-3 diaminobenzidine 
(DAB) (Dako) enzyme-substrate complexes were used for im-
munohistochemical staining. HRP-conjugated rabbit anti-goat 
IgG (Sigma) was used for Western blot analysis.
Heart weight/body weight (HW/BW) ratio
At 8 weeks, mice were weighted and executed by cervical ver-
tebrae luxation. The heart was taken out and washed with 
normal saline to remove excess connective tissues and ves-
sels. Bibulous paper was used to absorb any residual saline 
on the samples before they were weighed and measured. A 
Vernier caliper was employed to measure cardiomyocyte size.
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Real-time polymerase chain reaction
Total RNA was extracted with TRIzol reagent (Invitrogen) and 
reverse-transcribed to cDNA using the PrimeScript RT reagent 
Kit (Takara) according to the manufacturer’s protocol. Primers 
were synthesized by Sangon Biotech (Shanghai, China). All 
primer sequences are provided in Table 1. Quantitative PCR 
was performed using a 7500 Real-time PCR System and Power 
SYBR MasterMix (Applied Biosystems) following the manufac-
turer’s instructions. Relative mRNA expression was calculated 
using the 2–DDCt method with the Ct values normalized to b-ac-
tin as internal control.
Protein preparation and western blot analysis
Total protein was extracted from tissues using RIPA buffer con-
taining phenylmethylsulfonyl fluoride. After protein separation 
on 10% SDS-polyacrylamide gels and transfer to nitrocellu-
lose, membranes were blocked with 5% (m/V) non-fat milk in 
0.05% Tween-20/phosphate-buffered saline (PBS-T). The mem-
branes were then washed (3×10 min) with PBS-T and further 
incubated with primary antibodies against MTA1 (1: 1000), 
HIF-1a (1: 200), VEGF (1: 200), CD34 (1: 200), ERG (1: 1000), 
AQP5 (1: 1000), SPB (1: 1000), b-catenin (1: 1000), or b-actin 
(1: 3000) for 1.5 h at 37°C. After additional washes, the mem-
branes were treated with anti-goat IgG HRP-conjugated sec-
ondary antibody (1: 10,000) in 5% non-fat milk-PBS-T for 1 h 
and washed again as above. Finally, an enhanced chemilumi-
nescence system (Amersham Pharmacia) was used to develop 
the blots. Exposure times ranged from 40 s to 15 min. Signal 
intensities were semi-quantified and values were normalized 
to those of loading controls. Relative expression is present-
ed in arbitrary units.
Immunohistochemistry
Paraffin sections (4 μm) were placed on poly-L-lysine-coat-
ed glass slides and stained according to standard immuno-
histochemical procedures. Briefly, after deparaffinization and 
washing in PBS, the sections were covered with 3% hydrogen 
peroxide in PBS for 15 min at room temperature to block en-
dogenous peroxidase activity. The sections were blocked with 
5% bovine serum albumin and incubated with primary anti-
bodies against MTA1 (1: 50), HIF-1a (1: 100), VEGF (1: 200), 
a-SMA (1: 100), ERG (1: 200) or CD34 (1: 200) in a humidified 
chamber at 4°C overnight. After washing, the sections were 
incubated with biotinylated goat anti-rabbit IgG (Boster Bio-
Technology Co., LTD) for 1 h at 37°C. PBS (pH 7.2) was used to 
rehydrate the samples, followed by incubation with the avi-
din-biotinylated peroxidase complex for 45 min at 37°C. After 
washing in PBS, peroxidase activity was revealed using DAB 
according to the manufacturer’s instructions.
Red blood cell staining
After fixation, red blood cells were stained for hemoglobin us-
ing a pseudoperoxidase reaction with DAB. First, slides were 
placed in 0.05% DAB, 1% imidazole 1 M, and 0.1% H2O2 in 
50 mM Tris-HCl buffer (pH 7.4) for 10 min in a dark environ-
ment. They were then washed with demineralized water and 
counterstained using Harris hematoxylin for 2 min accord-
ing to the manufacturer’s instructions. Finally, the slides were 
rinsed with demineralized water and washed in running tap 
water to improve staining, dehydrated, cleared, and mounted.
Transmission electron microscopy
Transmission electron microscopy was performed as follows: 
tissues were quickly removed and fixed with 2.5% glutaralde-
hyde, post-fixed in 1% osmium tetroxide in the same buffer 
for 1 h and dehydrated in acetone for embedding in Araldite. 
Semi-thin sections (thickness of 1 um) were stained with an 
alkaline solution of toluidine blue. Ultrathin sections were con-
trasted with lead citrate and uranyl acetate, and examined 
with an electron microscope.
Statistical analysis
Data are presented as mean ± standard error of the mean. 
Student’s t-test and Mann-Whitney U test were used for para-
metric and nonparametric data, respectively. All statistical anal-
yses were performed using GraphPad Prism V5.0 (GraphPad 
Software). Statistical significance was set at p<0.05.
Name Direction Sequences
MTA1
Forward
Reverse
5’-AGGAGGAAGAGGAGGAGGAGAATAT-3’
5’-GGCACCAGATCACATAGTTGTG-3’
ERG
Forward
Reverse
5’-GTGGGCGGTGAAAGAATATGG-3’
5’-CTTTGGACTGAGGGGTGAGG-3’
CD34
Forward
Reverse
5’-GATAATTGCCATTCCCATGC-3’
5’-CAGACTCCACCACCTTACTTGAC-3’
HIF-1a
Forward
Reverse
5’-AACAGTGACAAAAGACCGTA-3’
5’-ATGACTCCTTTTCCTGCTCT-3’
VEGF
Forward
Reverse
5’-GAGATGAGCTTCCTACAGCACAACA-3’
5’-GGAACATTTACACGTCTGCGGATCT-3’
b-actin
Forward
Reverse
5’-CGTTGACATCCGTAAAGACCTC-3’
5’-ACAGAGTACTTGCGCTCAGGAG-3’
Table 1. Primers for real-time PCR.
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Figure 1.  Expression of MTA1 in various tissues and organs of adult mice and during embryonic lung development. (A, B) MTA1 protein 
and mRNA expression by Western blotting and real-time PCR, respectively, in different tissues of adult wild-type mice. 
(C) immunohistochemical analysis demonstrates MTA1 expression in the lungs at E16.5, E18.5, and P1. (D) MTA1 protein 
expression in the lungs at E16.5, E18.5, and P1. Scale bar, 50 μm. (D, E) A gradual, but significant decrease in the protein and 
mRNA levels of MTA1 was observed in the lungs from E16.5 to P1. Actin controls in A and D were blotted in parallel gels with 
the same amount of loading. n=6, * P<0.05, ** P<0.01, *** P<0.001.
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Figure 2.  MTA1 deficiency increases infant mortality and impairs growth. (A) Postnatal mortality shows that over one-third of 
homozygous MTA1-KO mice died within 7 days after birth compared to wild-type mice. (B, C) MTA1-deficient mice that 
did survive exhibited retarded growth and markedly decreased body weight compared to wild-type mice. n=30, * P<0.05, 
** P<0.01, *** P<0.001.
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Results
MTA1 is abundantly expressed in mouse lung tissue
To determine the distribution of the MTA1 protein and its role 
in mice, we examined the levels of MTA1 in different tissues 
of mice by Western blot analysis. Our data indicate that MTA1 
protein was present at high levels in the lungs, testis, and ova-
ries; at moderate levels in the brain, liver, mammary glands, 
and kidneys; at low levels in the heart, stomach, colon, and 
spleen; and could not be detected in the uterus (Figure 1A). 
The levels of MTA1 in various tissues corroborated well with 
MTA1 mRNA levels determined by real-time PCR (Figure 1B). 
An immunohistochemical analysis indicated that MTA1 was 
generally localized within cell nuclei (Figure 1C). We noticed a 
gradual decrease in the protein and mRNA levels of MTA1 ex-
pression during development from embryonic day 16.5 (E16.5) 
to postnatal day 1 (P1) in wild-type mice (Figure 1D, 1E). These 
findings suggest that MTA1 is expressed at high levels in the 
lung tissue, and the role of MTA1 in lung development was 
examined in subsequent studies.
MTA1 deficiency increases infant mortality and retards 
growth
To investigate the function of MTA1 in mouse development, 
we evaluated mice at E18.5 and P7, which gave an estimate 
of postnatal mortality in the first week after birth. We found 
that, compared to wild-type mice, over one-third of homozy-
gous MTA1-KO mice died within the first 7 days after birth 
(Figure 2A). However, some MTA1-KO mice did survive, ex-
hibiting retarded growth and decreased body weight com-
pared to wild-type littermates (Figure 2B, 2C). These observa-
tions suggest that MTA1 depletion increases infant mortality 
and inhibits growth.
MTA1-deficient animals exhibit myocardial hypertrophy 
and pulmonary arterial hypertension
To further determine the role of MTA1 in the lungs, we inves-
tigated the effect of MTA1 deficiency on cardiac structure, be-
cause pulmonary capillary damage could cause pulmonary hy-
pertension. The HW/BW ratio is an established parameter for 
evaluating cardiac structure. We report a significant increase 
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Figure 3.  MTA1-KO mice present cardiac hypertrophy. (A) Representative images of HE-stained MTA1-KO and wild-type cardiac 
structures. Compared with wild-type animals, cardiomyocytes of MTA1-KO mice were bigger and hypertrophied (p<0.05). 
(B) The HW/BW ratio was significantly higher in MTA1-KO than in wild-type mice at 8 weeks of age (p<0.05), indicating 
MTA1 deficiency induced myocardial hypertrophy in adult mice. (C, D) The size of right ventricular cardiomyocytes was 
significantly larger in MTA1-KO than in wild-type mice at 8 weeks of age (n=10), * P<0.05, ** P<0.01, *** P<0.001. (E) a-SMA 
immunostaining highlights pulmonary artery wall thickening and hypertension in MTA1-KO mice (n=6). Scale bar, 50 μm.
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in the HW/BW ratio in MTA1-KO compared to wild-type mice 
at 8 weeks of age (p<0.05; Figure 3A, 3B). Accordingly, MTA1 
deficiency might induce myocardial hypertrophy in the adult 
mice due to a reduction of mature capillaries in pulmonary 
alveoli. To analyze the cardiac structure in further detail, we 
performed hematoxylin-eosin (HE) staining to calculate the 
thickness of the right ventricular wall. Consistent with an in-
crease in the HW/BW ratio, cardiomyocytes’ size was also sig-
nificantly higher in MTA1-KO mice compared to wild-type mice 
(Figure 3C, 3D). The observation that MTA1 deficiency induced 
pulmonary artery wall thickening and pulmonary arterial hy-
pertension was further validated by a-SMA immunostaining 
(Figure 3E). These results further indicate that MTA1 deficien-
cy leads to pulmonary hypertension and myocardial hypertro-
phy in adult mice.
MTA1 deficiency impairs the formation of capillary beds
To evaluate if capillary beds were affected in the lungs of 
MTA1-deficient mice, we used HE and Heme staining to assess 
the status of pulmonary capillaries and red blood cells (RBC). 
We noticed significantly fewer capillary beds and RBC in the 
lungs of MTA1-KO animals compared to wild-type littermates 
(Figure 4A–4C). This finding was confirmed at the E18.5 and 
2M stage by transmission electron microscopy (Figure 4D). 
Immunohistochemistry results indicated that the expression lev-
el of CD34 was decreased in the lung tissue of MTA1-KO mice at 
E18.5 and 2M compared to the wild-type group (Figure 5A, 5B). 
However, the percentages of ERG positive cells were similar 
in the alveolar walls of wild-type and MTA1-KO mice at E18.5 
and were increased significantly in the MTA1-deficient mice of 
2M (Figure 5C). Accordantly, the same expression tendencies 
at both the protein and mRNA levels were confirmed at the 
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Figure 4.  MTA1-KO mice display reduced vascularization of the lungs. (A–C) HE and Heme staining demonstrate a significantly reduced 
number of pulmonary capillaries and red blood cells in the lungs of MTA1-KO mice compared to wild-type animals. n=10, 
Scale bar, 50 μm, *P<0.05, ** P<0.01, *** P<0.001. (D) Transmission electron micrograph showing a similar decrease in the 
number of pulmonary capillaries () and red blood cells (RBC, ☆) at E18.5 and 2M in MTA1-KO mice. n=6, Scale bar, 5 μm.
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Figure 5.  MTA1 deficiency impairs the formation of pulmonary capillary beds. (A, B) Immunohistochemistry results showed fewer 
CD34-positive cells in the lungs of MTA1-KO animals compared to wild-type mice at E18.5 and 2M. n=10, Scale bar, 50 μm, 
* P<0.05, ** P<0.01. (C) The percentages of ERG positive cells were similar in the alveolar walls of wild-type and MTA1-
KO mice at E18.5 but were increased significantly in the MTA1-deficient mice of 2M. n=10, Scale bar, 50 μm. (D) Western 
blot analysis highlights the downregulation of CD34 in the lungs of MTA1-KO mice at E18.5 and 2M compared to wild-
type animals. ERG levels were similar at E18.5 but increased significantly in the MTA1-deficient mice of 2M. (E, F) The same 
expression tendencies of CD34 and ERG at mRNA levels were confirmed at the E18.5 and 2M stage by real-time PCR analysis. 
n=10, * P<0.05.
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Figure 6.  Regulation of HIF-1a expression by MTA1. (A, B) Real-time PCR and Western blot analysis results indicated that MTA1 
correlates well with many lung development-related factors such as VEGF, AQP5, SPB, and b-catenin. (C, D) Western blot and 
real-time PCR showed significant upregulation of HIF-1a and VEGF in 293T and MLE-12 cells overexpressing MTA1 36 h after 
transfection. n=3, * P<0.05, ** P<0.01, *** P<0.001.
E18.5 and 2M stage by Western blot and real-time PCR analy-
sis (Figure 5D–5F). These results indicate that MTA1 deficien-
cy could reduce the number of mature capillaries in pulmo-
nary alveoli, suggesting MTA1 is involved in the development 
and maturation of pulmonary alveolar capillaries.
MTA1 deficiency reduces HIF-1a and VEGF levels in lung
MTA1 has been reported to modulate the stability of HIF-1a 
through deacetylation by the MTA1/HDAC complex [6]. In ad-
dition to this, real-time PCR and Western blot analysis results 
indicated that MTA1 also correlates well with other lung devel-
opment-related factors such as VEGF, AQP5, SPB, and b-catenin 
(Figure 6A, 6B). To investigate the regulatory role of MTA1 on 
the generation of pulmonary capillaries via HIF-1a stabilization, 
we examined the effect of MTA1 on the status and gene ex-
pression of HIF-1a and VEGF in cell models. As expected, MTA1 
overexpression in both 293T and MLE-12 cells led to increased 
expression of HIF-1a and VEGF compared to the control vec-
tor (Figure 6C), which was consistent with the increased HIF-
1a and VEGF mRNA levels (Figure 6D). These findings suggest 
that MTA1 expression stabilizes HIF-1a, possibly via deacety-
lation. This, in turn upregulates the downstream expression of 
VEGF and induces angiogenesis. However, this pathway was 
largely disrupted in the MTA1-KO mice, and results in the ob-
served deficient formation of pulmonary capillaries.
Discussion
MTA1 is a component of NuRD, which regulates gene ex-
pression as well as protein deacetylation in association with 
HDACs [20,21]. Previous studies have suggested that MTA1 
enhances the stability of HIF-1a by recruiting HDAC1 in can-
cer cells [5] and that MTA1 enhances the expression of VEGF 
by increasing the transcriptional activity of HIF-1a [6]. In gen-
eral, increased MTA1 expression in cancer has been shown to 
be closely associated with poor prognosis, increased tumor an-
giogenesis, and increased migration and metastasis [4,22–24].
However, cellular motility also plays a significant role in a va-
riety of normal biological functions. For example, Li et al. have 
shown that MTA1 is abundantly expressed in the lungs of 
mice [2]. The underlying basis of the role of MTA1 in angiogen-
esis includes its upregulation under hypoxic conditions and sta-
bilization of HIF-1a by promoting its MTA1/HDAC1-dependent 
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Figure 7.  A correlation between the expression of MTA1 and HIF-
1a in the lungs. MTA1 is an active angiogenic regulator 
that deacetylates HIF-1a. The MTA1- HIF-1a axis feed 
into VEGF expression and the formation of pulmonary 
capillaries.
deacetylation on lysine 532 [5]. HIF1 is also fundamental to 
glycolysis, erythropoiesis, angiogenesis, and the prevention of 
apoptosis in response to low oxygen pressure, which enables 
cellular adaptation and survival in extreme conditions [25,26]. 
HIF-1a activity appears to depend largely on the availabili-
ty of HIF-1a with a shorter half-life [5]. Regulation of HIF-1a 
availability appears to occur predominantly at the post-trans-
lation level via protein stabilization. VEGF, one of the HIF-1a 
primary targets, has been demonstrated to be involved in the 
pathogenesis of various lung diseases, such as bronchial pul-
monary dysplasia, acute lung injury, emphysema, and pulmo-
nary hypertension [13]. In this context, hypoxia is one of the 
strongest activators of VEGF expression [27–29]. Taken togeth-
er, MTA1, HIF-1a, and VEGF are all related to oxygen supply, 
making their expression and function potentially essential in 
the lungs. However, regulation of HIF-1a protein stability by 
MTA1 within the lungs was previously unknown.
To understand the effect of MTA1 deficiency on the forma-
tion of pulmonary alveolar capillaries and the expression of 
HIF-1a, we investigated the functional consequences of MTA1 
deficiency in the lungs of MTA1-KO mice. We observed that 
MTA1 was expressed at high levels in murine lung tissue and 
its depletion resulted in reduced VEGF and HIF-1a levels, few-
er pulmonary alveolar capillary beds, increased infant mortal-
ity, and retarded growth. These data suggest that MTA1 pro-
motes the formation of pulmonary capillaries by deacetylating 
HIF-1a and, subsequently, modulating HIF-1a stability, increas-
ing downstream VEGF expression, and inducing angiogenesis.
Conclusions
In summary, this study identified a correlation between the 
expression of MTA1 and HIF-1a in the lungs, in which MTA1 
is an active angiogenic regulator responsible for deacetylating 
HIF-1a. The MTA1/HIF-1a axis then affects VEGF expression 
and the formation of pulmonary capillaries (Figure 7). These 
data enhance our understanding of MTA1 function during de-
velopment and suggest that MTA1 may be a potential ther-
apeutic target, providing new avenues for the diagnosis and 
treatment of related pulmonary diseases.
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